Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012739
Filing Date
2017-11-13
Accepted
2017-11-09 19:42:21
Documents
33
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 215746
2 ex31-1.htm EX-31.1 18989
3 ex31-2.htm EX-31.2 18997
4 ex32-1.htm EX-32.1 7838
5 ex32-2.htm EX-32.2 8384
  Complete submission text file 0001493152-17-012739.txt   960016

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enzb-20170930.xml EX-101.INS 60114
7 XBRL SCHEMA FILE enzb-20170930.xsd EX-101.SCH 12882
8 XBRL CALCULATION FILE enzb-20170930_cal.xml EX-101.CAL 18991
9 XBRL DEFINITION FILE enzb-20170930_def.xml EX-101.DEF 47457
10 XBRL LABEL FILE enzb-20170930_lab.xml EX-101.LAB 88221
11 XBRL PRESENTATION FILE enzb-20170930_pre.xml EX-101.PRE 79050
Mailing Address 8440 W. LAKE MEAD SUITE 214 LAS VEGAS NV 89128
Business Address 8440 W. LAKE MEAD SUITE 214 LAS VEGAS NV 89128 702-907-0615
EnzymeBioSystems (Filer) CIK: 0001471968 (see all company filings)

EIN.: 270464302 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-53854 | Film No.: 171192456
SIC: 2834 Pharmaceutical Preparations